SRR12763282

SRA first seen 2021

Provenance — who produced it, who reused it

Linked to 1 papers in the literature. Roles are inferred factual signals (who deposited the data vs who reused it), with counts — never a judgement about any author.

Reused by

1 further paper cites this accession but reuse could not be confirmed.

Deep data QC

70/100 · C

Standardized, field-standard QC computed by touching the data — every metric states how it was obtained · evidence: measured

What this means

claude:haiku

This NovaSeq 6000 amplicon dataset for SARS-CoV-2 contains 2.1 million short reads (617.8 million bases) with excellent quality (99.1% Q20, 96.6% Q30) and zero N-content. The 38.2% GC content is slightly lower than most SARS-CoV-2 amplicon runs, though still within expected bounds. Good read depth and quality support confident consensus calling and variant discovery; suitable for moderately-sized surveillance studies.

Data type / assay

amplicon

Organism

Severe acute respiratory syndrome coronavirus 2

Instrument

Illumina NovaSeq 6000

Platform

ILLUMINA

Read type

short-read

Files available

FASTQ (raw reads)

N numbers (samples, groups)

1 runs

Metrics (value · how obtained)

checksum ok yes reported

total bases 617879884 reported

total reads 2116027 reported

n content pct 0 measured

pct q20 bases 99.1 measured

pct q30 bases 96.6 measured

gc content pct 38.2 measured

mean read length 146 measured

mean base quality 36.5 measured

adapter content pct 13.63 measured

duplication rate pct 90.48 measured

How this grade was computed

Weighted mean of 2 scored metric(s) → 70/100

The C grade is a transparent weighted average. Each metric below scored from 0–100% against the published amplicon thresholds, weighted by its importance; nothing is hidden or subjective.

pct q30 bases 96.6 measured ×1 100%

adapter content pct 13.63 measured ×0.5 10%

QC cost 16 s compute

measured = computed from the data · extrapolated/reported = derived or from the repository · dq-1.0